MAFP IcFRACGP Part 1 Practice Questions - Conjoint MAFP IcFRACGP Examination Part 1 (Applied Knowledge Test & Key Feature Problems) Exam

Access More Questions

A 55-year-old Chinese woman with a 10-year history of Type 2 Diabetes Mellitus presents to the primary care clinic for her quarterly review. Her current medications are Metformin 1g BD and Gliclazide 80mg BD. Her HbA1c is 8.2%. She has no history of cardiovascular disease, but her eGFR is 42 mL/min/1.73m2. According to the Malaysian CPG 2020, which of the following is the most appropriate modification to her therapy?

Add a Sodium-Glucose Co-transporter 2 (SGLT2) inhibitor (e.g., Dapagliflozin). Increase Gliclazide to 160mg BD. Initiate basal insulin at bedtime. Stop Metformin and start Pioglitazone.

Correct Answer:

Add a Sodium-Glucose Co-transporter 2 (SGLT2) inhibitor (e.g., Dapagliflozin).

Access more questions from this quiz

Continue to MAFP icFRACGP Part 1 Practice Questions - Conjoint MAFP icFRACGP Examination Part 1 (Applied Knowledge Test & Key Feature Problems) Exam for more practice questions and the full quiz experience.

Access More Questions